Prevalence of acute reactions to iopromide: Postmarketing surveillance study of 74,717 patients

Acta Radiologica

Volumn 49, Issue 8, 2008, Pages 902-911

  Kopp, A F ^a   Mortele, K J ^b   Cho, Y D ^b   Palkowitsch, P ^b   Bettmann, M A ^b   Claussen, C D ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

Adverse drug reactions; Computer tomography; Contrast agents; Radiography

Indexed keywords

AGENTS; CHEMOTHERAPY; COLOR; CONCENTRATION (PROCESS); CONTRAST MEDIA; DRUG DELIVERY; DRUG DOSAGE; HEALTH; IMAGING TECHNIQUES; MEDICAL IMAGING; OPTICAL PROPERTIES; RANGE FINDING; REACTION RATES; REFRIGERATORS;

ADVERSE DRUG REACTION; ADVERSE DRUG REACTIONS; BERLIN , GERMANY; CLINICAL PRACTICES; CM REACTIONS; COMPUTER TOMOGRAPHY; CONTRAST AGENT; CONTRAST AGENTS; DESCRIPTORS; IODINATED CONTRAST AGENTS; IODINATED X-RAY CONTRAST MEDIA; IOPROMIDE; NON-IONIC; OVERALL RATE; PATIENT INFORMATION; POTENTIALLY FATAL; RADIOGRAPHY; RISK FACTORS; SURVEILLANCE STUDY;

RATE CONSTANTS;

CONTRAST MEDIUM; DRUG DERIVATIVE; IOHEXOL; IOPROMIDE;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; INCIDENCE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KOREA; MALE; MIDDLE AGED; MULTICENTER STUDY; POSTMARKETING SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICS; UNITED STATES;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DRUG HYPERSENSITIVITY; FEMALE; GERMANY; HUMANS; INCIDENCE; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; IOHEXOL; KOREA; MALE; MIDDLE AGED; PREVALENCE; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES;

EID: 51849120796     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850802282811     Document Type: Article

References (24)

1. Bettmann MA. Frequentlyasked questions: iodinated contrast agents. Radiographics 2004;24 Suppl 1:S3-10.
2. Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006; 12:210-5.
3. Vogl TJ, Honold E, Wolf M, Mohajeri H, Hammer-stingl R. Safetyof iobitridol in the general population and at-risk patients. Eur Radiol 2006;16:1288-97.
4. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safetyof Contrast Media. Radiology 1990;175:621-8.
5. Mortele KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safetyin a large urban teaching hospital. Am J Roentgenol 2005;184:31-44.
6. Palmer FJ. The RACR surveyof intravenous contrast media reactions. Final report. Australas Radiol 1988;32: 426-8.
7. Petersein J, Peters CR, Wolf M, Hamm B. Results of the safetyand efficacy of iobitridol in more than 61,000 patients. Eur Radiol 2003;13:2006-11.
8. Schrott KM, Behrends B, Clauss W, Kaufmann J, Lehnert J. Iohexol in excretoryurography. Results of drug monitoring. Fortschr Med 1986;104:153-6.
9. Munechika H, Hiramatsu Y, Kudo S, Sugimura K, Hamada C, Yamaguchi K, et al. A prospective surveyof delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 2003;13:185-94.
10. Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolalitycontrast media: a meta-analysis. Am J Roentgenol 1991;156:825-32.
11. Bush WH, Swanson DP. Acute reactions to intravas-cular contrast media: types, risk factors, recognition, and specific treatment. Am J Roentgenol 1991;157:1153-61.
12. Lasser EC, Berry CC, Talner LB, Santini LC, Lang EK, Gerber FH, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987;317:845-9.
13. Shehadi WH. Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology 1982;143:11-7.
14. Bettmann MA, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology 1997;203:611-20.
15. Dahlstrom K, Shaw DD, Clauss W, Andrew E, Sveen K. Summaryof U.S. and European intravascular experience with iohexol based on the clinical trial program. Invest Radiol 1985;20 Suppl 1:S117-21.
16. Miles SG, Rasmussen JF, Litwiller T, Osik A. Safe use of an intravenous power injector for CT: experience and protocol. Radiology 1990;176:69-70.
17. Jacobs JE, Birnbaum BA, Langlotz CP. Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 1998;209:411-6.
18. Lasser EC. Contrast reactions. Eked data from contrast-reaction surveys. Invest Radiol 1990;25 Suppl 1:S14-5.
19. Narita S, Goldblum RM, Watson CS, Brooks EG, Estes DM, Curran EM, et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect 2007;115:48-52.
20. Morcos SK, Thomsen HS, Webb JA. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 2001;11:1720-8.
21. Delaney A, Carter A, Fisher M. The prevention of anaphylactoid reactions to iodinated radiological contrast media: a systematic review. BMC Med Imaging 2006;6:2.
22. American College of Radiology. American College of Radiologymanual on contrast media. 5th ed. Reston, Va: American College of Radiology; 2004.
23. Michel A, Abudulah A, Schumann W. Spontaneous reporting of adverse drug reactions: estimation of underreporting for contrast media reactions in 14 countries. Pharmacoepidemiol Drug Saf 2001;10(S1):S34.
24. Joelson S, Joelson IB, Wallander MA. Geographical variation in adverse event reporting rates in clinical trials. Pharmacoepidemiol Drug Saf 1997;6 Suppl 3: S31-5.